nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—NCOA4—thyroid cancer	0.0121	0.0908	CbGpPWpGaD
Ixabepilone—TUBB8—head—thyroid cancer	0.0112	0.0692	CbGeAlD
Ixabepilone—TUBB3—Afatinib—Vandetanib—thyroid cancer	0.00918	0.417	CbGdCrCtD
Ixabepilone—TUBB2B—saliva-secreting gland—thyroid cancer	0.00832	0.0513	CbGeAlD
Ixabepilone—TUBB—saliva-secreting gland—thyroid cancer	0.00787	0.0485	CbGeAlD
Ixabepilone—TUBB2A—saliva-secreting gland—thyroid cancer	0.00783	0.0483	CbGeAlD
Ixabepilone—TUBB6—saliva-secreting gland—thyroid cancer	0.00773	0.0476	CbGeAlD
Ixabepilone—TUBB3—head—thyroid cancer	0.00766	0.0472	CbGeAlD
Ixabepilone—TUBB1—head—thyroid cancer	0.00749	0.0461	CbGeAlD
Ixabepilone—TUBB4B—saliva-secreting gland—thyroid cancer	0.00672	0.0414	CbGeAlD
Ixabepilone—TUBB2B—trachea—thyroid cancer	0.00642	0.0395	CbGeAlD
Ixabepilone—TUBB—trachea—thyroid cancer	0.00607	0.0374	CbGeAlD
Ixabepilone—TUBB2A—trachea—thyroid cancer	0.00604	0.0372	CbGeAlD
Ixabepilone—TUBB6—trachea—thyroid cancer	0.00596	0.0367	CbGeAlD
Ixabepilone—TUBB4B—Afatinib—Vandetanib—thyroid cancer	0.00567	0.258	CbGdCrCtD
Ixabepilone—TUBB—Loss of Nlp from mitotic centrosomes—PCM1—thyroid cancer	0.00555	0.0415	CbGpPWpGaD
Ixabepilone—TUBB4A—thyroid gland—thyroid cancer	0.00525	0.0324	CbGeAlD
Ixabepilone—TUBB4B—trachea—thyroid cancer	0.00518	0.0319	CbGeAlD
Ixabepilone—TUBB2B—thyroid gland—thyroid cancer	0.00508	0.0313	CbGeAlD
Ixabepilone—TUBB—Centrosome maturation—PCM1—thyroid cancer	0.00492	0.0368	CbGpPWpGaD
Ixabepilone—TUBB—thyroid gland—thyroid cancer	0.00481	0.0296	CbGeAlD
Ixabepilone—TUBB2A—thyroid gland—thyroid cancer	0.00478	0.0294	CbGeAlD
Ixabepilone—TUBB6—thyroid gland—thyroid cancer	0.00471	0.029	CbGeAlD
Ixabepilone—TUBB4A—head—thyroid cancer	0.00466	0.0287	CbGeAlD
Ixabepilone—TUBB4A—Loss of Nlp from mitotic centrosomes—PCM1—thyroid cancer	0.0046	0.0344	CbGpPWpGaD
Ixabepilone—TUBB—Regulation of PLK1 Activity at G2/M Transition—PCM1—thyroid cancer	0.00452	0.0338	CbGpPWpGaD
Ixabepilone—TUBB2B—head—thyroid cancer	0.00451	0.0278	CbGeAlD
Ixabepilone—TUBB6—Erlotinib—Vandetanib—thyroid cancer	0.00432	0.196	CbGdCrCtD
Ixabepilone—TUBB2A—head—thyroid cancer	0.00424	0.0261	CbGeAlD
Ixabepilone—TUBB4B—Loss of Nlp from mitotic centrosomes—PCM1—thyroid cancer	0.00421	0.0315	CbGpPWpGaD
Ixabepilone—TUBB6—head—thyroid cancer	0.00418	0.0258	CbGeAlD
Ixabepilone—TUBB4B—thyroid gland—thyroid cancer	0.0041	0.0252	CbGeAlD
Ixabepilone—TUBB4A—Centrosome maturation—PCM1—thyroid cancer	0.00408	0.0305	CbGpPWpGaD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—PCM1—thyroid cancer	0.00374	0.028	CbGpPWpGaD
Ixabepilone—TUBB4B—Centrosome maturation—PCM1—thyroid cancer	0.00373	0.0279	CbGpPWpGaD
Ixabepilone—TUBB4B—head—thyroid cancer	0.00364	0.0224	CbGeAlD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—PCM1—thyroid cancer	0.00342	0.0256	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—PCM1—thyroid cancer	0.00339	0.0254	CbGpPWpGaD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—PCM1—thyroid cancer	0.00334	0.025	CbGpPWpGaD
Ixabepilone—TUBB4A—lymph node—thyroid cancer	0.00326	0.0201	CbGeAlD
Ixabepilone—TUBB2B—lymph node—thyroid cancer	0.00315	0.0194	CbGeAlD
Ixabepilone—TUBB—lymph node—thyroid cancer	0.00299	0.0184	CbGeAlD
Ixabepilone—TUBB2A—lymph node—thyroid cancer	0.00297	0.0183	CbGeAlD
Ixabepilone—TUBB6—lymph node—thyroid cancer	0.00293	0.018	CbGeAlD
Ixabepilone—TUBB6—Afatinib—Vandetanib—thyroid cancer	0.00283	0.128	CbGdCrCtD
Ixabepilone—TUBB4A—G2/M Transition—PCM1—thyroid cancer	0.00281	0.021	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—PCM1—thyroid cancer	0.00277	0.0207	CbGpPWpGaD
Ixabepilone—TUBB4B—G2/M Transition—PCM1—thyroid cancer	0.00257	0.0192	CbGpPWpGaD
Ixabepilone—TUBB4B—lymph node—thyroid cancer	0.00255	0.0157	CbGeAlD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—PCM1—thyroid cancer	0.00253	0.019	CbGpPWpGaD
Ixabepilone—TUBB—Loss of Nlp from mitotic centrosomes—CDK1—thyroid cancer	0.0023	0.0172	CbGpPWpGaD
Ixabepilone—TUBB—Centrosome maturation—CDK1—thyroid cancer	0.00204	0.0152	CbGpPWpGaD
Ixabepilone—TUBB4A—Loss of Nlp from mitotic centrosomes—CDK1—thyroid cancer	0.0019	0.0142	CbGpPWpGaD
Ixabepilone—TUBB—Regulation of PLK1 Activity at G2/M Transition—CDK1—thyroid cancer	0.00187	0.014	CbGpPWpGaD
Ixabepilone—Ileus—Doxorubicin—thyroid cancer	0.00177	0.0026	CcSEcCtD
Ixabepilone—Thrombosis—Doxorubicin—thyroid cancer	0.00177	0.0026	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00177	0.00259	CcSEcCtD
Ixabepilone—Insomnia—Vandetanib—thyroid cancer	0.00176	0.00257	CcSEcCtD
Ixabepilone—Paraesthesia—Vandetanib—thyroid cancer	0.00174	0.00256	CcSEcCtD
Ixabepilone—Erythema multiforme—Sorafenib—thyroid cancer	0.00174	0.00256	CcSEcCtD
Ixabepilone—TUBB4B—Loss of Nlp from mitotic centrosomes—CDK1—thyroid cancer	0.00174	0.013	CbGpPWpGaD
Ixabepilone—Laryngitis—Doxorubicin—thyroid cancer	0.00174	0.00255	CcSEcCtD
Ixabepilone—Dyspnoea—Vandetanib—thyroid cancer	0.00173	0.00254	CcSEcCtD
Ixabepilone—Hyperaesthesia—Epirubicin—thyroid cancer	0.00173	0.00253	CcSEcCtD
Ixabepilone—Cardiac disorder—Sorafenib—thyroid cancer	0.00171	0.00251	CcSEcCtD
Ixabepilone—Decreased appetite—Vandetanib—thyroid cancer	0.00169	0.00247	CcSEcCtD
Ixabepilone—TUBB4A—Centrosome maturation—CDK1—thyroid cancer	0.00169	0.0126	CbGpPWpGaD
Ixabepilone—Neuritis—Doxorubicin—thyroid cancer	0.00168	0.00247	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00168	0.00246	CcSEcCtD
Ixabepilone—Fatigue—Vandetanib—thyroid cancer	0.00167	0.00245	CcSEcCtD
Ixabepilone—Angiopathy—Sorafenib—thyroid cancer	0.00167	0.00245	CcSEcCtD
Ixabepilone—Immune system disorder—Sorafenib—thyroid cancer	0.00166	0.00244	CcSEcCtD
Ixabepilone—Mediastinal disorder—Sorafenib—thyroid cancer	0.00166	0.00244	CcSEcCtD
Ixabepilone—Pain—Vandetanib—thyroid cancer	0.00166	0.00243	CcSEcCtD
Ixabepilone—Constipation—Vandetanib—thyroid cancer	0.00166	0.00243	CcSEcCtD
Ixabepilone—Dysphonia—Epirubicin—thyroid cancer	0.00165	0.00242	CcSEcCtD
Ixabepilone—Alopecia—Sorafenib—thyroid cancer	0.00163	0.00239	CcSEcCtD
Ixabepilone—Mental disorder—Sorafenib—thyroid cancer	0.00161	0.00237	CcSEcCtD
Ixabepilone—Malnutrition—Sorafenib—thyroid cancer	0.0016	0.00235	CcSEcCtD
Ixabepilone—Hyperaesthesia—Doxorubicin—thyroid cancer	0.0016	0.00234	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00159	0.00233	CcSEcCtD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—CDK1—thyroid cancer	0.00155	0.0116	CbGpPWpGaD
Ixabepilone—TUBB4B—Centrosome maturation—CDK1—thyroid cancer	0.00154	0.0115	CbGpPWpGaD
Ixabepilone—Muscle spasms—Sorafenib—thyroid cancer	0.00154	0.00226	CcSEcCtD
Ixabepilone—Body temperature increased—Vandetanib—thyroid cancer	0.00153	0.00225	CcSEcCtD
Ixabepilone—Abdominal pain—Vandetanib—thyroid cancer	0.00153	0.00225	CcSEcCtD
Ixabepilone—Dysphonia—Doxorubicin—thyroid cancer	0.00153	0.00224	CcSEcCtD
Ixabepilone—Bone disorder—Epirubicin—thyroid cancer	0.0015	0.0022	CcSEcCtD
Ixabepilone—Anaemia—Sorafenib—thyroid cancer	0.00148	0.00217	CcSEcCtD
Ixabepilone—Lacrimation increased—Epirubicin—thyroid cancer	0.00147	0.00216	CcSEcCtD
Ixabepilone—Syncope—Sorafenib—thyroid cancer	0.00144	0.00211	CcSEcCtD
Ixabepilone—Leukopenia—Sorafenib—thyroid cancer	0.00144	0.00211	CcSEcCtD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—CDK1—thyroid cancer	0.00142	0.0106	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Sorafenib—thyroid cancer	0.00141	0.00207	CcSEcCtD
Ixabepilone—TUBB6—Orphan transporters—RXRA—thyroid cancer	0.00141	0.0105	CbGpPWpGaD
Ixabepilone—TUBB2B—Orphan transporters—RXRA—thyroid cancer	0.00141	0.0105	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—CDK1—thyroid cancer	0.0014	0.0105	CbGpPWpGaD
Ixabepilone—Cough—Sorafenib—thyroid cancer	0.0014	0.00205	CcSEcCtD
Ixabepilone—Asthenia—Vandetanib—thyroid cancer	0.00139	0.00204	CcSEcCtD
Ixabepilone—Bone disorder—Doxorubicin—thyroid cancer	0.00139	0.00204	CcSEcCtD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—CDK1—thyroid cancer	0.00138	0.0104	CbGpPWpGaD
Ixabepilone—Coordination abnormal—Epirubicin—thyroid cancer	0.00138	0.00203	CcSEcCtD
Ixabepilone—Pruritus—Vandetanib—thyroid cancer	0.00137	0.00201	CcSEcCtD
Ixabepilone—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00137	0.00201	CcSEcCtD
Ixabepilone—Arthralgia—Sorafenib—thyroid cancer	0.00137	0.002	CcSEcCtD
Ixabepilone—Myalgia—Sorafenib—thyroid cancer	0.00137	0.002	CcSEcCtD
Ixabepilone—Lacrimation increased—Doxorubicin—thyroid cancer	0.00136	0.002	CcSEcCtD
Ixabepilone—TUBB3—Orphan transporters—RXRA—thyroid cancer	0.00136	0.0101	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00136	0.00199	CcSEcCtD
Ixabepilone—Diarrhoea—Vandetanib—thyroid cancer	0.00133	0.00195	CcSEcCtD
Ixabepilone—TUBB2A—Orphan transporters—RXRA—thyroid cancer	0.00131	0.00983	CbGpPWpGaD
Ixabepilone—Colitis—Epirubicin—thyroid cancer	0.0013	0.00191	CcSEcCtD
Ixabepilone—Infection—Sorafenib—thyroid cancer	0.0013	0.00191	CcSEcCtD
Ixabepilone—Skin exfoliation—Epirubicin—thyroid cancer	0.0013	0.0019	CcSEcCtD
Ixabepilone—Shock—Sorafenib—thyroid cancer	0.00129	0.00189	CcSEcCtD
Ixabepilone—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00129	0.00962	CbGpPWpGaD
Ixabepilone—TUBB1—Orphan transporters—RXRA—thyroid cancer	0.00129	0.00961	CbGpPWpGaD
Ixabepilone—Nervous system disorder—Sorafenib—thyroid cancer	0.00128	0.00188	CcSEcCtD
Ixabepilone—Dizziness—Vandetanib—thyroid cancer	0.00128	0.00188	CcSEcCtD
Ixabepilone—Thrombocytopenia—Sorafenib—thyroid cancer	0.00128	0.00188	CcSEcCtD
Ixabepilone—Coordination abnormal—Doxorubicin—thyroid cancer	0.00128	0.00187	CcSEcCtD
Ixabepilone—Neuropathy—Epirubicin—thyroid cancer	0.00127	0.00187	CcSEcCtD
Ixabepilone—Skin disorder—Sorafenib—thyroid cancer	0.00127	0.00187	CcSEcCtD
Ixabepilone—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00127	0.00186	CcSEcCtD
Ixabepilone—Anorexia—Sorafenib—thyroid cancer	0.00125	0.00183	CcSEcCtD
Ixabepilone—Oesophagitis—Epirubicin—thyroid cancer	0.00124	0.00182	CcSEcCtD
Ixabepilone—Vomiting—Vandetanib—thyroid cancer	0.00123	0.00181	CcSEcCtD
Ixabepilone—Rash—Vandetanib—thyroid cancer	0.00122	0.00179	CcSEcCtD
Ixabepilone—Dermatitis—Vandetanib—thyroid cancer	0.00122	0.00179	CcSEcCtD
Ixabepilone—Headache—Vandetanib—thyroid cancer	0.00122	0.00178	CcSEcCtD
Ixabepilone—Colitis—Doxorubicin—thyroid cancer	0.00121	0.00177	CcSEcCtD
Ixabepilone—Skin exfoliation—Doxorubicin—thyroid cancer	0.0012	0.00176	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00119	0.00175	CcSEcCtD
Ixabepilone—Neuropathy—Doxorubicin—thyroid cancer	0.00118	0.00173	CcSEcCtD
Ixabepilone—Sepsis—Epirubicin—thyroid cancer	0.00118	0.00173	CcSEcCtD
Ixabepilone—Dyspnoea—Sorafenib—thyroid cancer	0.00117	0.00171	CcSEcCtD
Ixabepilone—TUBB4A—G2/M Transition—CDK1—thyroid cancer	0.00116	0.0087	CbGpPWpGaD
Ixabepilone—TUBB4A—Orphan transporters—RXRA—thyroid cancer	0.00115	0.00863	CbGpPWpGaD
Ixabepilone—Nausea—Vandetanib—thyroid cancer	0.00115	0.00169	CcSEcCtD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—CDK1—thyroid cancer	0.00115	0.00858	CbGpPWpGaD
Ixabepilone—Oesophagitis—Doxorubicin—thyroid cancer	0.00115	0.00168	CcSEcCtD
Ixabepilone—Decreased appetite—Sorafenib—thyroid cancer	0.00114	0.00167	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00113	0.00166	CcSEcCtD
Ixabepilone—Fatigue—Sorafenib—thyroid cancer	0.00113	0.00166	CcSEcCtD
Ixabepilone—Pain—Sorafenib—thyroid cancer	0.00112	0.00164	CcSEcCtD
Ixabepilone—Constipation—Sorafenib—thyroid cancer	0.00112	0.00164	CcSEcCtD
Ixabepilone—Sepsis—Doxorubicin—thyroid cancer	0.00109	0.0016	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.00108	0.00807	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00107	0.00157	CcSEcCtD
Ixabepilone—TUBB4B—G2/M Transition—CDK1—thyroid cancer	0.00106	0.00796	CbGpPWpGaD
Ixabepilone—TUBB4B—Orphan transporters—RXRA—thyroid cancer	0.00106	0.00789	CbGpPWpGaD
Ixabepilone—Hot flush—Epirubicin—thyroid cancer	0.00105	0.00154	CcSEcCtD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—CDK1—thyroid cancer	0.00105	0.00784	CbGpPWpGaD
Ixabepilone—Menopausal symptoms—Epirubicin—thyroid cancer	0.00104	0.00153	CcSEcCtD
Ixabepilone—Abdominal pain—Sorafenib—thyroid cancer	0.00104	0.00152	CcSEcCtD
Ixabepilone—Body temperature increased—Sorafenib—thyroid cancer	0.00104	0.00152	CcSEcCtD
Ixabepilone—Lethargy—Epirubicin—thyroid cancer	0.001	0.00147	CcSEcCtD
Ixabepilone—Hyponatraemia—Epirubicin—thyroid cancer	0.000989	0.00145	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000985	0.00144	CcSEcCtD
Ixabepilone—Hot flush—Doxorubicin—thyroid cancer	0.000974	0.00143	CcSEcCtD
Ixabepilone—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000966	0.00142	CcSEcCtD
Ixabepilone—Hypersensitivity—Sorafenib—thyroid cancer	0.000965	0.00141	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—PCM1—thyroid cancer	0.000965	0.00721	CbGpPWpGaD
Ixabepilone—Asthenia—Sorafenib—thyroid cancer	0.00094	0.00138	CcSEcCtD
Ixabepilone—Lethargy—Doxorubicin—thyroid cancer	0.00093	0.00136	CcSEcCtD
Ixabepilone—Pruritus—Sorafenib—thyroid cancer	0.000926	0.00136	CcSEcCtD
Ixabepilone—Dehydration—Epirubicin—thyroid cancer	0.000916	0.00134	CcSEcCtD
Ixabepilone—Hyponatraemia—Doxorubicin—thyroid cancer	0.000915	0.00134	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000911	0.00134	CcSEcCtD
Ixabepilone—Hypokalaemia—Epirubicin—thyroid cancer	0.000896	0.00131	CcSEcCtD
Ixabepilone—Diarrhoea—Sorafenib—thyroid cancer	0.000896	0.00131	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000894	0.00668	CbGpPWpGaD
Ixabepilone—Gastritis—Epirubicin—thyroid cancer	0.000871	0.00128	CcSEcCtD
Ixabepilone—Muscular weakness—Epirubicin—thyroid cancer	0.000868	0.00127	CcSEcCtD
Ixabepilone—Dizziness—Sorafenib—thyroid cancer	0.000866	0.00127	CcSEcCtD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—TP53—thyroid cancer	0.000852	0.00637	CbGpPWpGaD
Ixabepilone—Dysphagia—Epirubicin—thyroid cancer	0.000851	0.00125	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—thyroid cancer	0.000847	0.00124	CcSEcCtD
Ixabepilone—Vomiting—Sorafenib—thyroid cancer	0.000833	0.00122	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—thyroid cancer	0.000829	0.00122	CcSEcCtD
Ixabepilone—Angina pectoris—Epirubicin—thyroid cancer	0.000829	0.00122	CcSEcCtD
Ixabepilone—Rash—Sorafenib—thyroid cancer	0.000826	0.00121	CcSEcCtD
Ixabepilone—Dermatitis—Sorafenib—thyroid cancer	0.000825	0.00121	CcSEcCtD
Ixabepilone—Headache—Sorafenib—thyroid cancer	0.00082	0.0012	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000818	0.00611	CbGpPWpGaD
Ixabepilone—Pancytopenia—Epirubicin—thyroid cancer	0.000808	0.00119	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—thyroid cancer	0.000806	0.00118	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—thyroid cancer	0.000804	0.00118	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—PCM1—thyroid cancer	0.000799	0.00598	CbGpPWpGaD
Ixabepilone—Neutropenia—Epirubicin—thyroid cancer	0.000796	0.00117	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000791	0.00116	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—thyroid cancer	0.000787	0.00115	CcSEcCtD
Ixabepilone—Nausea—Sorafenib—thyroid cancer	0.000778	0.00114	CcSEcCtD
Ixabepilone—Weight decreased—Epirubicin—thyroid cancer	0.00077	0.00113	CcSEcCtD
Ixabepilone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00077	0.00576	CbGpPWpGaD
Ixabepilone—Angina pectoris—Doxorubicin—thyroid cancer	0.000767	0.00112	CcSEcCtD
Ixabepilone—Pneumonia—Epirubicin—thyroid cancer	0.000763	0.00112	CcSEcCtD
Ixabepilone—Infestation NOS—Epirubicin—thyroid cancer	0.000759	0.00111	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—thyroid cancer	0.000759	0.00111	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—thyroid cancer	0.000748	0.0011	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—thyroid cancer	0.000746	0.00109	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000744	0.00109	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—thyroid cancer	0.00074	0.00108	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—thyroid cancer	0.00074	0.00108	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—thyroid cancer	0.000738	0.00108	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—thyroid cancer	0.000736	0.00108	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000732	0.00107	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—PCM1—thyroid cancer	0.000731	0.00547	CbGpPWpGaD
Ixabepilone—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000718	0.00105	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—thyroid cancer	0.000712	0.00104	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—thyroid cancer	0.000706	0.00104	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—thyroid cancer	0.000702	0.00103	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—thyroid cancer	0.000702	0.00103	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—thyroid cancer	0.00069	0.00101	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000688	0.00101	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—thyroid cancer	0.000685	0.001	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—thyroid cancer	0.000684	0.001	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—thyroid cancer	0.000684	0.001	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000682	0.001	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—thyroid cancer	0.000681	0.000999	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—thyroid cancer	0.000678	0.000994	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—thyroid cancer	0.000673	0.000986	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000669	0.000982	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—thyroid cancer	0.000668	0.000979	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000664	0.000974	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000659	0.00493	CbGpPWpGaD
Ixabepilone—Erythema multiforme—Epirubicin—thyroid cancer	0.000644	0.000944	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—thyroid cancer	0.000637	0.000933	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—thyroid cancer	0.000633	0.000929	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—thyroid cancer	0.000632	0.000927	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—thyroid cancer	0.00063	0.000924	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000627	0.00092	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000622	0.000913	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000619	0.000908	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—thyroid cancer	0.000618	0.000906	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—thyroid cancer	0.000618	0.000906	CcSEcCtD
Ixabepilone—Immune system disorder—Epirubicin—thyroid cancer	0.000615	0.000902	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—thyroid cancer	0.000614	0.0009	CcSEcCtD
Ixabepilone—Chills—Epirubicin—thyroid cancer	0.000611	0.000896	CcSEcCtD
Ixabepilone—Alopecia—Epirubicin—thyroid cancer	0.000602	0.000883	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—thyroid cancer	0.000597	0.000875	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—thyroid cancer	0.000596	0.000874	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—thyroid cancer	0.000593	0.00087	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—TPR—thyroid cancer	0.000589	0.00441	CbGpPWpGaD
Ixabepilone—Eye disorder—Doxorubicin—thyroid cancer	0.000589	0.000864	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—thyroid cancer	0.000585	0.000858	CcSEcCtD
Ixabepilone—Angiopathy—Doxorubicin—thyroid cancer	0.000572	0.000839	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—thyroid cancer	0.00057	0.000836	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—thyroid cancer	0.000569	0.000835	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000568	0.000833	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—thyroid cancer	0.000566	0.000829	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—thyroid cancer	0.000557	0.000817	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—thyroid cancer	0.000552	0.00081	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—thyroid cancer	0.000549	0.000805	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—thyroid cancer	0.000548	0.000804	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000546	0.00408	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000545	0.00408	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000545	0.00408	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000545	0.00408	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—CP—thyroid cancer	0.000545	0.00408	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000537	0.00401	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000537	0.00401	CbGpPWpGaD
Ixabepilone—Syncope—Epirubicin—thyroid cancer	0.000532	0.00078	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—thyroid cancer	0.000531	0.000778	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—thyroid cancer	0.000527	0.000774	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000527	0.00394	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000527	0.00394	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Epirubicin—thyroid cancer	0.000521	0.000764	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000518	0.00387	CbGpPWpGaD
Ixabepilone—Cough—Epirubicin—thyroid cancer	0.000517	0.000759	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00051	0.00381	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—CP—thyroid cancer	0.00051	0.00381	CbGpPWpGaD
Ixabepilone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000507	0.00379	CbGpPWpGaD
Ixabepilone—Anaemia—Doxorubicin—thyroid cancer	0.000507	0.000744	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—thyroid cancer	0.000505	0.00074	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—thyroid cancer	0.000505	0.00074	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—thyroid cancer	0.000505	0.00074	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000502	0.00375	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000501	0.000735	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000499	0.00373	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000499	0.00373	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000499	0.00373	CbGpPWpGaD
Ixabepilone—Syncope—Doxorubicin—thyroid cancer	0.000492	0.000722	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—thyroid cancer	0.000491	0.00072	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000491	0.00367	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TPR—thyroid cancer	0.000488	0.00365	CbGpPWpGaD
Ixabepilone—Oedema—Epirubicin—thyroid cancer	0.000484	0.00071	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000482	0.000707	CcSEcCtD
Ixabepilone—Infection—Epirubicin—thyroid cancer	0.000481	0.000705	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—thyroid cancer	0.000479	0.000702	CcSEcCtD
Ixabepilone—Shock—Epirubicin—thyroid cancer	0.000476	0.000698	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—thyroid cancer	0.000475	0.000696	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—thyroid cancer	0.000474	0.000695	CcSEcCtD
Ixabepilone—Skin disorder—Epirubicin—thyroid cancer	0.00047	0.000689	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—thyroid cancer	0.000467	0.000685	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—thyroid cancer	0.000467	0.000685	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—thyroid cancer	0.000467	0.000685	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000464	0.00068	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—thyroid cancer	0.000461	0.000676	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—thyroid cancer	0.000452	0.000663	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000448	0.00335	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—CP—thyroid cancer	0.000448	0.00335	CbGpPWpGaD
Ixabepilone—Oedema—Doxorubicin—thyroid cancer	0.000448	0.000657	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000447	0.00335	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TPR—thyroid cancer	0.000447	0.00334	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000447	0.00334	CbGpPWpGaD
Ixabepilone—Infection—Doxorubicin—thyroid cancer	0.000445	0.000652	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000441	0.000647	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000441	0.00329	CbGpPWpGaD
Ixabepilone—Shock—Doxorubicin—thyroid cancer	0.000441	0.000646	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000439	0.000644	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000438	0.000643	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—thyroid cancer	0.000438	0.000642	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—thyroid cancer	0.000435	0.000638	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—thyroid cancer	0.000435	0.000637	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—thyroid cancer	0.000431	0.000633	CcSEcCtD
Ixabepilone—Anorexia—Doxorubicin—thyroid cancer	0.000427	0.000626	CcSEcCtD
Ixabepilone—Decreased appetite—Epirubicin—thyroid cancer	0.000421	0.000617	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—thyroid cancer	0.000418	0.000614	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000418	0.000613	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—thyroid cancer	0.000417	0.000612	CcSEcCtD
Ixabepilone—Pain—Epirubicin—thyroid cancer	0.000414	0.000607	CcSEcCtD
Ixabepilone—Constipation—Epirubicin—thyroid cancer	0.000414	0.000607	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00041	0.00306	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—CP—thyroid cancer	0.00041	0.00306	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000408	0.00305	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000408	0.00305	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000408	0.000598	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—thyroid cancer	0.000405	0.000594	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000403	0.00301	CbGpPWpGaD
Ixabepilone—Paraesthesia—Doxorubicin—thyroid cancer	0.000402	0.00059	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CDK1—thyroid cancer	0.000399	0.00299	CbGpPWpGaD
Ixabepilone—Dyspnoea—Doxorubicin—thyroid cancer	0.000399	0.000585	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000396	0.00058	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000394	0.00295	CbGpPWpGaD
Ixabepilone—Decreased appetite—Doxorubicin—thyroid cancer	0.000389	0.000571	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000387	0.000567	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—thyroid cancer	0.000386	0.000566	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—thyroid cancer	0.000383	0.000562	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—thyroid cancer	0.000383	0.000562	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—thyroid cancer	0.000383	0.000561	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—thyroid cancer	0.000383	0.000561	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000382	0.00286	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000373	0.00279	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.00037	0.00277	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000366	0.000537	CcSEcCtD
Ixabepilone—Hypersensitivity—Epirubicin—thyroid cancer	0.000357	0.000523	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—thyroid cancer	0.000354	0.000519	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—thyroid cancer	0.000354	0.000519	CcSEcCtD
Ixabepilone—Asthenia—Epirubicin—thyroid cancer	0.000347	0.000509	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000343	0.00257	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000343	0.00257	CbGpPWpGaD
Ixabepilone—Pruritus—Epirubicin—thyroid cancer	0.000342	0.000502	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000338	0.00253	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000335	0.00251	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000331	0.00248	CbGpPWpGaD
Ixabepilone—Diarrhoea—Epirubicin—thyroid cancer	0.000331	0.000486	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CDK1—thyroid cancer	0.000331	0.00247	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Doxorubicin—thyroid cancer	0.00033	0.000484	CcSEcCtD
Ixabepilone—Asthenia—Doxorubicin—thyroid cancer	0.000321	0.000471	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000321	0.0024	CbGpPWpGaD
Ixabepilone—Dizziness—Epirubicin—thyroid cancer	0.00032	0.000469	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—thyroid cancer	0.000317	0.000465	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000314	0.00235	CbGpPWpGaD
Ixabepilone—Vomiting—Epirubicin—thyroid cancer	0.000308	0.000451	CcSEcCtD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000307	0.00229	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000307	0.00229	CbGpPWpGaD
Ixabepilone—Diarrhoea—Doxorubicin—thyroid cancer	0.000306	0.000449	CcSEcCtD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000305	0.00228	CbGpPWpGaD
Ixabepilone—Rash—Epirubicin—thyroid cancer	0.000305	0.000447	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—thyroid cancer	0.000305	0.000447	CcSEcCtD
Ixabepilone—Headache—Epirubicin—thyroid cancer	0.000303	0.000445	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—CDK1—thyroid cancer	0.000303	0.00226	CbGpPWpGaD
Ixabepilone—Dizziness—Doxorubicin—thyroid cancer	0.000296	0.000434	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—TERT—thyroid cancer	0.000288	0.00215	CbGpPWpGaD
Ixabepilone—Nausea—Epirubicin—thyroid cancer	0.000287	0.000422	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—thyroid cancer	0.000285	0.000417	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—thyroid cancer	0.000282	0.000414	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—thyroid cancer	0.000282	0.000414	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000282	0.00211	CbGpPWpGaD
Ixabepilone—Headache—Doxorubicin—thyroid cancer	0.000281	0.000411	CcSEcCtD
Ixabepilone—Nausea—Doxorubicin—thyroid cancer	0.000266	0.00039	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000258	0.00193	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000249	0.00186	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TERT—thyroid cancer	0.000238	0.00178	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TERT—thyroid cancer	0.000218	0.00163	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.000186	0.00139	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—thyroid cancer	0.000166	0.00124	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.000154	0.00115	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.000141	0.00105	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—thyroid cancer	0.000138	0.00103	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000132	0.000988	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—thyroid cancer	0.000126	0.000943	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—thyroid cancer	0.00011	0.000819	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MINPP1—thyroid cancer	9.71e-05	0.000726	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—thyroid cancer	9.08e-05	0.000679	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—thyroid cancer	8.3e-05	0.000621	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	8.25e-05	0.000617	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CHST14—thyroid cancer	7.76e-05	0.00058	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HPGD—thyroid cancer	6.25e-05	0.000468	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TPR—thyroid cancer	3.59e-05	0.000269	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.53e-05	0.000264	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.69e-05	0.000201	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—RXRA—thyroid cancer	2.26e-05	0.000169	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPARG—thyroid cancer	1.43e-05	0.000107	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.12e-05	8.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—thyroid cancer	9.79e-06	7.32e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKT1—thyroid cancer	5.64e-06	4.22e-05	CbGpPWpGaD
